North America IoT Infusion Pumps Market Outlook (2022-2033)

The North America IoT infusion pumps market size is expected to reach US$ 15,437.7 million by 2033 from US$ 3,962.6 million in 2024. The market is estimated to record a CAGR of 17.2% from 2025 to 2033.

Executive Summary and North America IoT Infusion Pumps Market Analysis:

The IoT infusion pumps market in North America is experiencing significant growth driven by the increasing demand for precision drug delivery, focus on medication error reduction & patient safety, growth of home infusion therapy. The North America IoT infusion pumps market is distinguished by its maturity, scale, and technological leadership. The region benefits from advanced healthcare infrastructure, high healthcare expenditure, and strong reimbursement mechanisms that encourage adoption of connected infusion technologies. Hospitals and clinics dominate usage, deploying IoT-enabled insulin pumps, chemotherapy delivery systems, and pain management devices to improve treatment precision and reduce adverse events. The U.S. leads the market, driven by its large diabetic and oncology patient base, while Canada emphasizes telemedicine integration to extend access to rural and underserved populations. Competitive dynamics are shaped by multinational corporations such as Baxter International, ICU Medical, and B. Braun, who offer advanced smart pump portfolios with interoperability and cybersecurity features. Local players contribute by focusing on affordability and niche applications. Partnerships between device manufacturers and electronic health record providers have created integrated ecosystems that enhance patient outcomes and operational efficiency. Overall, the North American market is characterized by strong innovation, regulatory oversight, and widespread adoption, positioning it as the global benchmark for IoT infusion pump deployment.

North America IoT Infusion Pumps Market Segmentation Analysis

Key segments that contributed to the derivation of the IoT infusion pumps market analysis are product, technology, application, and end user.

• By product, the IoT infusion pumps market is segmented into IoT insulin pumps, syringe infusion pumps, volumetric infusion pumps, ambulatory infusion pumps, patient-controlled analgesia pumps, and others. IoT insulin pumps dominated the market in 2024, driven by the rising diabetes prevalence and strong demand for connected glucose management solutions.
• By technology, the IoT infusion pumps market is segmented into Wi-Fi, Bluetooth, cellular, and others. Wi-Fi dominated the market in 2024, driven by reliable urban connectivity that enables seamless integration with hospital IT systems and telemedicine platforms.
• In terms of application, the market is segmented into chemotherapy delivery, diabetes management, pain management, nutritional infusion, and others. Chemotherapy delivery dominated the market in 2024, driven by increasing cancer incidence and the need for precise, IoT‑enabled drug infusion in oncology care.
• By end user, the market is segmented into hospitals & clinics, home care settings, and others. Hospitals & clinics dominated the market in 2024, driven by their role as primary healthcare providers seeking efficiency, accuracy, and cost reduction through IoT infusion technologies.

North America IoT Infusion Pumps Market Outlook

The North America IoT infusion pumps market is segmented into the United States, Canada, and Mexico. ​‍​‌‍​‍‌​Looking ahead, North America is expected to maintain its leadership in IoT infusion pump adoption, though growth will be moderate compared to emerging regions. Rising prevalence of diabetes and cancer continues to drive demand for connected insulin and chemotherapy pumps, while AI-powered predictive analytics are increasingly integrated into hospital workflows. Connectivity solutions are evolving, with Wi-Fi dominating urban hospitals and secure cloud-based platforms enabling interoperability across healthcare networks. Governments and private healthcare providers are prioritizing preventive healthcare and digital transformation, embedding IoT infusion pumps into national health strategies and care delivery models. Private sector investment is particularly strong, with providers leveraging IoT technologies to differentiate services and attract patients seeking higher standards of care. Challenges remain around cybersecurity, interoperability, and cost pressures, particularly in balancing innovation with affordability. Nevertheless, the outlook remains highly positive, with IoT infusion pumps positioned to reduce hospital admissions, improve patient outcomes, and sustain North America’s leadership in digital health innovation.

North America IoT Infusion Pumps Market Country Insights   

Based on region, the North America IoT infusion pumps market is further segmented into the United States, Canada, and Mexico. The United States held the largest share in 2024.

Country-level dynamics highlight unique adoption patterns within North America. In the United States, IoT insulin pumps dominate due to high diabetes prevalence, strong insurance coverage, and rapid adoption of connected glucose management solutions. Chemotherapy infusion systems are widely used in oncology centers, reflecting the region’s high cancer incidence. Canada emphasizes telemedicine integration, deploying IoT infusion pumps to improve access in rural and underserved regions where healthcare infrastructure is limited. Hospitals and clinics remain the primary end users, leveraging IoT infusion pumps to enhance diagnostic accuracy, reduce monitoring costs, and streamline workflows. Private healthcare providers in both countries are investing heavily in advanced IoT technologies to differentiate services and attract patients seeking higher standards of care. Regulatory frameworks are robust, with the FDA in the U.S. and Health Canada ensuring compliance, safety, and innovation. Overall, country insights reveal a diverse but mature landscape, with North America setting global benchmarks in IoT infusion pump deployment while adapting strategies to local healthcare priorities.

North America IoT Infusion Pumps Market Company Profiles

Medtronic Plc, Moog, Inc., Abbott Laboratories, Boston Scientific Corporation, Baxter International Inc, Becton, Dickinson and Company, B. Braun SE, ICU Medical Inc., Fresenius Kabi AG, Terumo Corporation, are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

North America IoT Infusion Pumps Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

North America IoT Infusion Pumps Key Sources Referred:

• World Health Organization (WHO)
• Organisation for Economic Cooperation and Development (OECD)
• The World Bank Group
• Worldometer
• The Lancet
• International Bar Association
• International Trade Administration
• Eurostat